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Tyrosol plays a key role in fungal morphogenesis and biofilm development. Also, it has a 26 
remarkable antifungal effect at supraphysiological concentrations. However, the background 27 
of the antifungal effect remains unknown, especially in the case of non-albicans Candida 28 
species such as Candida parapsilosis. We examined the effect of tyrosol on the growth, 29 
adhesion, redox homeostasis, virulence, as well as on fluconazole susceptibility. To gain 30 
further insights into the physiological consequences of tyrosol treatment we also determined 31 
the caused genome-wide gene expression changes using RNA-Seq. Fifteen mM tyrosol 32 
caused significant growth inhibition within two hours of the addition of tyrosol, while the 33 
adhesion of yeast cells was not affected. Tyrosol increased the production of reactive oxygen 34 
species remarkably as revealed by the dichlorofluorescein-test, and it was associated with 35 
elevated superoxide dismutase, glutathione peroxidase, and catalase activities. The interaction 36 
between fluconazole and tyrosol was antagonistic. Tyrosol exposure resulted in 261 and 181 37 
differentially expressed genes with at least a 1.5-fold increase or decrease in expression, 38 
respectively, were selected for further study. Genes involved in ribosome biogenesis showed 39 
down-regulation, while genes related to oxidative stress response, and ethanol fermentation 40 
were up-regulated. In addition, tyrosol treatment up-regulated the expression of efflux pump 41 
genes including MDR1 and CDR1 and down-regulated the FAD2 and FAD3 virulence genes 42 
involved in desaturated fatty acid formation. Our data demonstrate that exogenous tyrosol 43 
significantly affects the physiology and gene expression of C. parapsilosis, which could 44 
contribute to the development of treatments targeting quorum-sensing in the future. 45 
 46 
Importance 47 
Candida-secreted quorum-sensing molecules (i.e., farnesol, tyrosol) are key regulators in 48 




altered biofilm formation, and synchronized expression of virulence factors. Moreover, they 50 
have a remarkable antifungal activity at supraphysiological concentrations. Limited data are 51 
available concerning the tyrosol-induced molecular and physiological effects in non-albicans 52 
species such as C. parapsilosis. In addition, the background of the previously observed 53 
antifungal effect caused by tyrosol remains unknown. This study revealed that tyrosol 54 
exposure enhanced the oxidative stress response and expression of efflux pump genes, while 55 
it inhibited growth and ribosome biogenesis, as well as several virulence-related genes. 56 
Metabolism was changed towards glycolysis and ethanol fermentation. Furthermore, the 57 
initial adherence was not influenced significantly in the presence of tyrosol. Our results 58 
provide several potential explanations of the previously observed antifungal effect. 59 
 60 






The proliferation and virulence of Candida cells are under strict cell density-based control 64 
mediated by various quorum-sensing molecules including farnesol and tyrosol (1-2). While 65 
farnesol induces the hyphae-to-yeast transition in Candida albicans, tyrosol has an opposite 66 
effect. Tyrosol is a tyrosine derivative molecule, which is released into the growth medium 67 
continuously during the exponential growth phase and is capable of decreasing the duration of 68 
the lag phase before cells begin germination (3). Previous studies have reported that the 69 
accumulation of tyrosol in the culture medium is directly related to the increase in fungal cell 70 
density (3-4). Moreover, 20 M tyrosol could stimulate the germ-tube and hypha formation in 71 
the early and intermediate stages of biofilm development (4). Based on the gene expression 72 
profile of C. albicans, tyrosol affects cell cycle regulation, DNA replication and chromosome 73 
segregation (3). Besides its role in fungal physiology, tyrosol also possess remarkable 74 
antifungal activity at supraphysiological concentrations (1 to 50 mM) both against planktonic 75 
and sessile Candida populations; therefore, its potential role in certain aspects of antifungal 76 
therapy has been postulated, e.g. in catheter-lock therapy (5-7). 77 
In recent years, alternative treatments targeting quorum-sensing against Candida species has 78 
become an intensively researched area; however, tyrosol remains a mysterious molecule and 79 
the exact background of its antifungal mechanism is still poorly understood (1-2, 8-10). In the 80 
case of C. albicans, both the transcriptional and physiological responses exerted by tyrosol 81 
have been addressed earlier (3-4) aiding the understanding of the observed antifungal effect 82 
against C. albicans. However, the tyrosol-induced physiological and molecular events, 83 
especially in non-albicans species remained unknown so far. Hereby, we report the effect of 84 
tyrosol at supraphysiological concentration on cell growth, adhesion, oxidative stress - related 85 




which may help understand the potential physiological and molecular background of its 87 





Materials and methods 90 
Fungal strain, culture medium and epithelial cell line 91 
The CLIB 214 C. parapsilosis (sensu stricto) reference strain was used in all experiments. 92 
The strain was maintained and cultured on Yeast Extract–Peptone–Dextrose (YPD) agar (1% 93 
yeast extract, 2% mycological peptone, 2% glucose, and 2% agar, pH 5.6). The Caco-2 94 
epithelial cell line was cultured as described earlier by Nemes et al. 2018 (11). The Caco-2 95 
cell line was obtained from the European Collection of Cell Cultures (ECACC, Salisbury, 96 
United Kingdom). Cells were grown in plastic cell culture flasks in Dulbecco’s Modified 97 
Eagle’s Medium (DMEM), supplemented with 3.7 g/L NaHCO3, 10% (v/v) heat-inactivated 98 
fetal bovine serum, 1% (v/v) non-essential amino acids solution, 0.584 g/L L-glutamine, 4.5 99 
g/L D-glucose, 100 IU/mL penicillin, and 100 mg/L streptomycin at 37 °C in the presence of 100 
5% CO2. The cells were routinely maintained by regular passaging and glutamine was 101 
supplemented by GlutaMax™. The cells used for adhesion and toxicity experiments were 102 
between passage numbers 20 and 40 (11). 103 
Tyrosol (2-(4-hydroxyphenyl) ethanol, Sigma, Budapest, Hungary) was prepared as 0.1 M 104 
stock solution in YPD or sterile physiological saline for physiology experiments and 105 
susceptibility testing or in vivo experiments, respectively. The stock solution of fluconazole 106 
was prepared in sterile distilled water and preserved according to the manufacturer’s 107 
instructions. The susceptibility testing of C. parapsilosis against tyrosol and fluconazole was 108 
performed using RPMI-1640 medium (with L-glutamine and without bicarbonate, pH 7.0 109 
with 3-(N-morpholino) propanesulfonic acid (MOPS); Sigma, Budapest, Hungary). 110 
 111 
Toxicity experiments 112 
In preliminary experiments, 100 M, 1 mM, 10 mM, and 15 mM tyrosol were evaluated in 113 




12) and the xCELLigence real time cell analysis (ACEA Biosciences, Inc., San Diego, USA) 115 
(13) where none of them caused relevant toxicity. As at 100 M, 1 mM, and 10 mM tyrosol 116 
concentrations the caused physiological and transcriptional changes that were less marked in 117 
C. parapsilosis. We focused exclusively on the effect of 15 mM tyrosol in further experiments 118 
in order to reveal the potential mechanisms of the antifungal effect. 119 
 120 
Growth conditions 121 
The pre-cultures were grown in YPD medium at 30 ºC at 3.7 Hz shaking frequency for 18 122 
hours then diluted to OD640 0.2 value (corresponding to 2.9 ± 0.5 × 10
6
 colony forming unit 123 
(CFU)/mL) in 20 mL of YPD and incubated at 37 ºC with 2.3 Hz shaking frequency (14). 124 
Following four hours incubation time, we added 15 mM tyrosol to the YPD cultures then 125 
growth was examined at one-hour intervals by determination of cell density both by means of 126 
measuring of the absorbance (at 640 nm) and by counting the living cells (CFU) as described 127 
previously (15). Morphological alterations were monitored using phase-contrast microscopy 128 
(Euromex Holland) with the MicroQ-W PRO camera, which was used to evaluate the ratio of 129 
yeast and pseudohyphae based on 100 cells per sample. Statistical comparison of the growth-130 
based data was performed by the paired Student’s t-test using GraphPad Prism 6.05 software. 131 
The results between treated and control values were considered significant if the p-value was 132 
<0.05. 133 
For reactive species production, antioxidant enzyme activities and RNA extraction, the yeast 134 
pre-cultures were diluted to 0.2 value (OD640) in YPD broth then cultures were grown for four 135 
hours at 37 ºC. Then YPD medium was supplemented with a final concentration of 15 mM 136 
tyrosol and fungal cells were collected two hours following tyrosol exposure by centrifugation 137 
(5 min, RCF = 4000 g, 4 °C). The cells were washed three times with phosphate-buffered 138 




Reactive species production and antioxidant enzyme activities 140 
Reactive species were measured in the presence or absence of tyrosol by a technique that 141 
converts 2’,7’ –dichlorofluorescin diacetate to 2’,7’–dichlorofluorescein (DCF) (Sigma, 142 
Budapest, Hungary). The produced DCF is directly proportional to the number of reactive 143 
species (16). 144 
Glutathione reductase, glutathione peroxidase, catalase and superoxide dismutase activities 145 
were determined as described earlier by Jakab et al. (2015) (16). Reactive species and enzyme 146 
activities were measured in three independent experiments and presented as mean ± standard 147 
deviation. Statistical comparison of reactive species and enzyme production data were 148 
performed by the paired Student’s t-test using GraphPad Prism 6.05 software. The results 149 
between treated and control values were considered significant if the p-value was <0.05. 150 
 151 
Adhesion experiments 152 
The Caco-2 epithelial cell line was inoculated with 1 × 10
5
 CFU/mL C. parapsilosis in order 153 
to evaluate the adhesion of fungal cells as described previously (17-18). In the adhesion assay, 154 
Caco-2 and C. parapsilosis cells were co-incubated for one hour in DMEM medium at 37 °C 155 
in the presence of 5% CO2 with and without 15 mM tyrosol. Afterwards, non-adherent fungal 156 
cells were removed by rinsing with phosphate-buffered saline, and the epithelial cells were 157 
fixed with 4% formaldehyde. Adherent C. parapsilosis cells were stained with calcofluor 158 
white (Sigma, Budapest, Hungary) and stained fungal cells were examined with a Zeiss 159 
AxioScope A1 fluorescence microscope with Zeiss AxioCam ICm1 camera (17-18). 160 
Adhesion (%) was calculated using the following formula: [(average cell count in the field × 161 
area of the well in μm2) / (area of the field in μm2 × inoculated fungal cells in each 162 
well)]×100. Adhesion was evaluated in three independent experiments and presented as the 163 




the paired Student’s t-test using GraphPad Prism 6.05 software. The results between treated 165 
and control values were considered significant if the p-value was <0.05. 166 
 167 
Evaluation of extracellular phospholipase and aspartic proteinase activity 168 
Extracellular phospholipase production of tyrosol-treated and untreated C. parapsilosis cells 169 
was examined on egg yolk medium [5.85% (w/v) NaCl, 0.05% (w/v) CaCl2 and 10% (v/v) 170 
sterile egg yolk (Sigma, Budapest, Hungary) in YPD medium]. Aspartic proteinase activity 171 
was evaluated on a solid medium supplemented with bovine serum albumin (Sigma, 172 
Budapest, Hungary). 173 
According to Kantarcioglu and Yücel (2002), 5 μL of 1 × 107 cells/mL suspensions were 174 
inoculated onto the surface of the agar plates (19). Colony diameters and the colony + 175 
precipitation zones were measured after seven days of incubation at 37 °C (20). 176 
 177 
Biofilm formation 178 
C. parapsilosis one-day-old biofilms were prepared as described previously (6, 21). Briefly, 179 
isolates were suspended in RPMI-1640 broth in concentration of 1 x 10
6
 cells/mL and aliquots 180 
of 100 µL were inoculated onto flat-bottom 96-well sterile microtitre plates (TPP, 181 
Trasadingen, Switzerland) in the presence or absence of 15 mM tyrosol and then incubated 182 
statically at 37°C for 24 hours (6, 21). One-day-old biofilm formation ability was determined 183 
by quantitative CFU determination of adhered cells and metabolic activity measurement using 184 
the XTT-assay (2,3-Bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide 185 
salt) (6, 21). Statistical comparison of CFU data and metabolic activity change between 186 
tyrosol-treated and untreated cells was performed by the Mann-Whitney test using the 187 
GraphPad Prism 6.05 software. The results between treated and control values were 188 





Susceptibility testing to fluconazole and tyrosol against planktonic cells and biofilms 191 
Planktonic minimum inhibitory concentration (MIC) determination was performed in line 192 
with the guideline of the M27-A3 document published by the Clinical Laboratory Standards 193 
Institute
 
(22). MICs of fluconazole and tyrosol were determined in RPMI-1640. The tested 194 
drug concentrations ranged from 0.03 to 2 mg/L for fluconazole, while tyrosol concentrations 195 
ranged from 0.5 to 60 mM. MICs were determined as the lowest drug concentration that 196 
produces at least 50% growth reduction compared to growth control (22). MICs represent 197 
three independent experiments per isolate and are expressed as the median. 198 
The examined concentrations for sessile MIC determination (sMIC) ranged from 0.125 to 8 199 
mg/L and from 0.5 to 60 mM for fluconazole and tyrosol, respectively. The preformed 200 
biofilms were washed three times with sterile physiological saline. Different drug 201 
concentrations in RPMI-1640 were added to biofilms and then the plates were incubated for 202 
24 hours at 37 °C Afterwards, sMIC determination was performed using the XTT-assay as 203 
described previously (6, 21). The percentage change in metabolic activity was calculated on 204 
the basis of absorbance (A) at 492 nm as 100% × (Awell-Abackground)/(Adrug-free well-Abackground). 205 
sMICs of the biofilms were defined as the lowest drug concentration resulting in at least 50% 206 
metabolic activity reduction compared to growth control cells (6, 21). sMICs represent three 207 
independent experiments per isolate and are expressed as the median value. 208 
 209 
Evaluation of interactions of fluconazole and tyrosol by fractional concentration index 210 
(FICI)  211 
Interaction between fluconazole and tyrosol was evaluated by the two-dimensional broth 212 
microdilution chequerboard assay against planktonic and sessile cells. Afterwards, the nature 213 




were the same as described above for the MIC determination. FICIs were calculated using the 215 













 stand for MICs of drugs A and B when used alone, and MICA
comb
 and 217 
MICB
comb
 represent the MIC values of drugs A and B at isoeffective combinations, 218 
respectively
 
(21, 23). FICIs were determined as the lowest ΣFIC. FICI values of ≤ 0.5 were 219 
defined as synergistic, between >0.5 and 4 as indifferent, and >4 as antagonistic. FICIs were 220 
determined in three independent experiments and median values were presented
 
(21, 23). 221 
 222 
In vivo experiments 223 
Groups of twelve BALB/C female mice (19-22g) were maintained in accordance with the 224 
Guidelines for the Care and Use of Laboratory Animals; experiments were approved by the 225 
Animal Care Committee of the University of Debrecen (permission no.: 12/2014 DEMÁB). 226 
Mice were immunosuppressed with four doses of intraperitoneal cyclophosphamide, i.e., four 227 
days prior to infection (150 mg/kg), one day prior to infection (100 mg/kg), two days post-228 
infection (100 mg/kg) and five days post-infection (100 mg/kg) (15). Mice were inoculated 229 
intravenously through the lateral tail vein with an infectious dose of 7 × 10
6
 CFU/mouse. The 230 
inoculum density was confirmed by plating serial dilutions onto Sabouraud dextrose agar 231 
plates. A five-day intraperitoneal treatment with daily 15 mM tyrosol was started 24 hours 232 
post-inoculation. On day six after infection, all mice were sacrificed, kidneys were removed, 233 
weighed, and homogenised aseptically. Homogenates were diluted 10-fold; aliquots of 0.1 mL 234 
of the undiluted and diluted homogenates were plated onto Sabouraud dextrose agar plates 235 
and incubated at 37 
o
C for 48 hours. The lower limit of detection was 50 CFU/g of tissue. 236 
Statistical analysis of the kidneys tissue burden was performed using an unpaired t-test (15). 237 
Kidney burden was analyzed using Kruskal-Wallis test with Dunn’s post-test (GraphPad 238 





RNA sequencing 241 
Total RNA was isolated from untreated control fungal cells and 15 mM tyrosol-treated 242 
cultures in three replicates. Freeze-dried cells were processed using TRISOL (Invitrogen, 243 
Austria) reagent according to Chomczynski (1993) (24).  244 
To obtain global transcriptome data, high-throughput mRNA sequencing was performed on 245 
an Illumina NextSeq sequencing platform. Total RNA sample quality was checked on an 246 
Agilent BioAnalyzer using the Eukaryotic Total RNA Nano Kit (Agilent Technologies, Inc., 247 
Santa Clara, CA, USA) according to the manufacturer’s protocol. Samples with RNA 248 
integrity number (RIN) value >7 were accepted for the library preparation process. RNA-Seq 249 
libraries were prepared from the total RNA using the TruSeq RNA Sample preparation kit 250 
(Illumina, San Diego, CA, USA) according to the manufacturer’s protocol. Sequencing 251 
libraries were normalised to the same molar concentration and pooled together. The library 252 
pool was sequenced on NextSeq500 instrument (Illumina, San Diego, CA, USA) generating 253 
single read 75bp-long sequencing reads. Fastq files were generated automatically after the 254 
sequencing run by Illumina BaseSpace. The library preparations and the sequencing run were 255 
performed by the Genomic Medicine and Bioinformatics Core Facility of the Department of 256 
Biochemistry and Molecular Biology, Faculty of Medicine, University of Debrecen, Hungary. 257 
Quality control of the sequencing data was performed using the FastQC package 258 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc) then the STAR RNA-Seq aligner 259 
was used to map the sequenced reads to the reference genome 260 
(C_parapsilosis_CDC317_version_s01m03r27_features_with_chromosome_sequences.gff.gz261 
;http://www.candidagenome.org/download/gff/C_parapsilosis_CDC317/archive/). The 262 
DESeq algorithm (StrandNGS software) was used to obtain normalised gene expression 263 




differences between treated and control groups were compared by moderated t-test; 265 
Benjamini-Hochberg False Discovery Rate was used for multiple testing correction and a 266 
corrected p < 0.05 was considered significant (differentially expressed genes). Up- and down-267 
regulated genes were defined as differentially expressed genes with more than 1.5-fold change 268 
(FC) values. The FC ratios were calculated from the FPKM values. 269 
 270 
Reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) assays 271 
To confirm the RNA-Seq results, ten up-regulated and six down-regulated genes, as well as 272 
nine genes without significant change in their expression were selected for the RT-qPCR 273 
analysis. 274 
The RT-qPCRs with Xceed qPCR SG 1-step 2x Mix Lo-ROX kit (Institute of Applied 275 
Biotechnologies, Czech Republic) were performed according to the protocol of the 276 
manufacturer using 500 ng of DNase- (Sigma, Budapest, Hungary) treated total RNA per 277 
reaction.  278 
Primer pairs (Table S1) were designed using OligoExplorer (version 1.1.) and Oligo Analyser 279 
(version 1.0.2) software and were purchased from Integrated DNA Technologies. Three 280 
parallel measurements were performed with each sample in a LightCycler® 480 II real-time 281 
PCR instrument (Roche, Switzerland) (25). Relative transcription levels were quantified with 282 
ΔΔCP values. ΔΔCP = ΔCPcontrol – ΔCPtreated, where ΔCPtreated = CPtested gene – CPreference gene 283 
measured from treated cultures and ΔCPcontrol = CPtested gene – CPreference gene measured from 284 
control cultures. CP values represented the qRT-PCR cycle numbers of crossing points. Three 285 
reference genes (ACT1, TUB2, TUB4) were tested. All of them showed stable transcription in 286 
our experiments. Only data calculated with the ACT1 (CPAR2_201570) transcription values 287 




measurements and ΔΔCP values significantly (p < 0.05) higher or lower than zero were 289 
determined using the Student’s t-test (25). 290 
 291 
Gene set enrichment analysis. 292 
Significant shared GO (gene ontology) terms were determined with the Candida Genome 293 
Database Gene Ontology Term Finder (http://www.candidagenome.org/cgi-294 
bin/GO/goTermFinder). Only hits with an adjusted p-value <0.05 were taken into 295 







Effect of tyrosol on growth, morphology, extracellular phospholipase, and proteinase 300 
production, biofilm formation as well as adhesion to Caco-2 cells. 301 
Growth of C. parapsilosis was examined following 15 mM tyrosol exposure in YPD. Adding 302 
tyrosol to preincubated cells resulted in a significant inhibition starting at six hours post-303 
inoculation, which was confirmed both by absorbance measurements and CFU determination. 304 
Growth was significantly inhibited within two hours of the addition of tyrosol both in terms of 305 
CFU change (8.25 ± 0.8 × 10
7
 and 4.5 ± 0.4 × 10
7 
CFU/mL for untreated control and tyrosol-306 
exposed cells, respectively) (p = 0.002), and of observed absorbance values (OD640) (p = 307 
0.002) (Fig. 1). The ratio of yeast and pseudohyphae was comparable between control (69.3 ± 308 
2.1% and 28.7 ± 3.5% for yeast and pseudohyphae, respectively) and treated cells (66.0 ± 309 
1.7% and 37.7 ± 1.5% for yeast and pseudohyphae, respectively) at two hours stress exposure 310 
time (p > 0.05). Tyrosol treatment did not influence significantly the extracellular proteinase 311 
activity (Pz values were 0.82 ± 0.04 and 0.80 ± 0.05 for untreated control and tyrosol-exposed 312 
cells, respectively p > 0.05). There was no remarkable phospholipase activity for untreated 313 
control and tyrosol-exposed cells (Pz value was 1.0), respectively. Biofilm forming ability 314 
was comparable with and without 15 mM tyrosol (4.9 ± 1.1 × 10
5 
and 6.4 ± 1.9 × 10
5 
living 315 
fungal cells at 24 hours for untreated control and tyrosol-exposed cells, respectively) (p > 316 
0.05); however, metabolic activity was significantly increased in the tyrosol treatment group 317 
(p = 0.001). Adhesion of C. parapsilosis to Caco-2 cells in the presence of tyrosol (4.2 ± 1.1% 318 
adherent cells) did not differ significantly from that observed with untreated control cells (3.1 319 
± 1.1% adherent cells) (p > 0.05). 320 
 321 




Tyrosol caused significantly higher reactive species production compared to untreated control 323 
cells (p < 0.001) as presented in Table 1. This tyrosol-related higher reactive species level was 324 
associated with elevated superoxide dismutase (p = 0.021), glutathione peroxidase (p = 0.012) 325 
and catalase activities (p = 0.013) in tyrosol-exposed cells (Table 1). In contrast, the measured 326 
glutathione reductase values were statistically comparable (p > 0.05) in tyrosol-treated and 327 
untreated Candida cells (Table 1). 328 
 329 
Susceptibility to fluconazole and tyrosol for planktonic and sessile C. parapsilosis 330 
The median planktonic MICs of fluconazole and tyrosol were 0.5 mg/L and 30 mM, 331 
respectively. FICI determination showed clear antagonistic interaction; the median FICI value 332 
of three independent experiments was 4.125. In case of the biofilms, the median MIC values 333 
were 4 mg/L and 30 mM for fluconazole and tyrosol, respectively, while the interaction was 334 
also antagonistic (FICI 4.5), similar that of the planktonic cells. 335 
 336 
In vivo experiments 337 
The daily treatment of 15 mM tyrosol decreased the fungal tissue burden in the kidneys at 338 
least by half a log degree, which corresponded to a significantly lower tissue burden (p = 339 
0.004) than seen in the untreated control (Fig. 2). 340 
 341 
Transcriptional profiling and RNA-Seq data validation 342 
Comparison of tyrosol-treated C. parapsilosis cells gene expression profile with that of 343 
untreated cells revealed 1,462 differentially expressed genes (Fig. S1). The qRT-PCR data of 344 
the selected 25 genes showed a strong correlation with the obtained RNA-Seq data (Fig. 3 and 345 




Tyrosol responsive genes were defined as differentially expressed genes with log2(FC)>0.585 347 
(up-regulated genes) or log2(FC)< –0.585 (down-regulated genes), where FC stands for fold 348 
change FPKM value (tyrosol treated vs. untreated cultures). Results of the gene set 349 
enrichment analysis of the 261 up-regulated and 181 down-regulated genes are presented in 350 
Table 2, S3, and S4 and summarised as below. 351 
 352 
Evaluation of tyrosol responsive genes 353 
Virulence-related genes 354 
Selected genes involved in genetic control of C. parapsilosis virulence were determined 355 
according to Tóth et al. (2019) (26). Virulence-related genes were significantly enriched 356 
within the tyrosol responsive up-regulated gene group according to the Fisher’s exact test 357 
(Table S4). Most of these 16 putative genes are involved in the biofilm production (e.g., 358 
CZF1, RBT1, IFD6, TEC1, HGC1, NRG1) (Fig. 4, Table 2, Tables S3 and S4). Out of the 359 
three down-regulated virulence-related genes, FAD2 and FAD3 (involved in saturated fatty 360 
acid formation) and MKC1 (a putative regulator of biofilm formation) are notable (Fig. 4, 361 
Table 2, Tables S3 and S4). It is noteworthy that tyrosol may also enhance its production 362 
through increasing the gene expression level of ADH5, which is involved in the tyrosine–363 
tyrosol conversion in C. albicans and in Saccharomyces cerevisiae (27). 364 
 365 
Cell wall-related genes 366 
Regarding cell wall assembly, the expression level of the putative genes PDC11, TDH3, 367 
ADH1 were upregulated by tyrosol treatment (Fig. 4, Table 2, Tables S3 and S4). 368 
 369 




Significant up-regulation of putative genes encoding antifungal drug transport proteins were 371 
observed (e.g., MDR1, CDR1, FCR1) (Fig. 4, Table 2, Tables S3 and S4). 372 
 373 
Metabolic pathway-related genes 374 
Selected genes involved in glucose catabolism were determined with the Candida Genome 375 
Database (http://www.candidagenome.org). Tyrosol exposure resulted in increased expression 376 
of several genes related to the “carbohydrate metabolic process” GO term including 377 
glycolysis (PGI1, PFK1, PFK2, TDH3, PGK1, GPM2, ENO1, CDC19) and fermentation 378 
(PDC11, PDC12, ADH1, ADH5, ADH7) genes but not the tricarboxylic acid cycle genes (Fig. 379 
4, Table 2, Tables S3 and S4). In contrast, tyrosol treatment led to a reduced expression of 380 
several genes (altogether 42 gene) involved in the transmembrane transport, including 10 381 
putative carbohydrate transport genes and 12 putative amino acid transport genes (Fig. 4, 382 
Table 2, Tables S3 and S4). Down-regulation of ribosome biogenesis genes (altogether 36 383 
genes) was also notable (Fig. 4, Table 2, Tables S3 and S4). 384 
 385 
Oxidative stress-related genes  386 
Genes belonging to the “response to oxidative stress” GO term were enriched in the tyrosol-387 
responsive up-regulated gene group (Fig. 4, Table 2, Tables S3 and S4). Altogether 18 genes 388 
were up-regulated after tyrosol treatment including CAT1, SOD4, CPAR2_803850, GPX1, 389 






Alternative treatments targeting fungal quorum-sensing has become an intensely researched 393 
area in the recent years (1-2, 5-8, 10). However, the majority of studies focused on farnesol-394 
related antifungal effects especially in the case of C. albicans (1, 10). Therefore, there are 395 
limited data about tyrosol-induced changes particularly among non-albicans species such as 396 
C. parapsilosis, which is the second most frequently isolated Candida species from blood in 397 
Asia, Latin-America, and several Mediterranean European countries (28). 398 
Previous studies reported that tyrosol has a potential antifungal effect similar to farnesol (5-7, 399 
29-31); moreover, it enhances the activity of caspofungin and micafungin against C. 400 
parapsilosis (6). Nevertheless, the exact physiological and transcriptional background of 401 
antifungal activity exerted by tyrosol remains to be elucidated. In the present study, tyrosol 402 
exposure was associated with physiological alterations as well as genome-wide transcriptional 403 
changes in C. parapsilosis. 404 
Concerning our growth-based experiments, a significant inhibitory effect was induced by the 405 
tyrosol concentration used, which is in line with previous investigations concerned with C. 406 
albicans, C. tropicalis, and C. krusei (5, 7, 29). The observed significant down-regulation of 407 
ribosome biogenesis genes is concordant with this marked growth inhibition. Another 408 
explanation for the antifungal effect of tyrosol is the induction of oxidative stress suggested 409 
by the increased level of reactive species in the presence of tyrosol. These reactive species can 410 
alter the ratio of saturated and unsaturated fatty acids in the cell membrane; furthermore, 411 
hydrogen peroxide and hydroxyl radicals cause irreversible damage to proteins, lipids and 412 
nucleic acids resulting in impaired viability (30). A well-known response of fungal species to 413 
reactive oxygen species is the rapid induction of oxidative stress detoxification at the mRNA 414 
level (30). In this study, several putative oxidative stress-responsive genes, CAT1, 415 




peroxidase) and SOD4 (encoding for superoxide dismutase), were up-regulated following 417 
exposure to tyrosol, which was associated with increased catalase, glutathione peroxidase and 418 
superoxide dismutase activities. Furthermore, CAP1, the major transcription factor in 419 
oxidative stress elimination, was also overexpressed following tyrosol exposure (30). 420 
The elevated levels of the reactive species may be explained by the disruption of 421 
polyunsaturated fatty acid (PUFA) metabolism. The synthesis of PUFAs is significantly 422 
down-regulated in tyrosol-treated cells, as tyrosol decreased the expression of genes FAD2 423 
and FAD3 encoding delta12-fatty acid desaturase and omega-3 fatty acid desaturase enzymes, 424 
respectively. These are orthologs of genes participating in PUFA synthesis in C. albicans (31-425 
32). PUFAs (stearidonic acid, eicosapentaenoic acid and docosapentaenoic acid) are major 426 
components of the cell membrane in C. parapsilosis, accounting for approximately 30% of 427 
the fatty acid content, and have a remarkable antioxidant effect (32). Tyrosol-induced 428 
inhibition of the expression of FAD2 and FAD3 found in this study, therefore, decreases the 429 
antioxidant level in cell membranes, which may contribute to the antifungal effect of tyrosol 430 
against C. albicans or C. parapsilosis (31-33). Although tyrosol was reported to exert an 431 
antioxidant effect, this was only measured at micromolar concentration (34), while the 432 
concentration used in this study was 15 mM. 433 
Tyrosol is a well-known regulator molecule in the biofilm formation of C. albicans (3-4); 434 
however, its exact role in the development of C. parapsilosis biofilms remained unknown. In 435 
this study, the ortholog of the C. albicans CZF1 gene, which is one of the key transcription 436 
factor of biofilm development in the C. parapsilosis, was up-regulated following the tyrosol 437 
exposure (35). CZF1 promotes the yeast-to-pseudohyphae transition (35); CZF1 mutants 438 
formed reduced colony wrinkling and the biofilms produced contained mainly yeast cells 439 
(35). Nonetheless, we did not observe higher rate of adherence and biofilm-forming ability in 440 




adhesion in C. albicans and C. glabrata, which is in line with the gene expression pattern 442 
observed and the biofilm formation experiments in our study with C. parapsilosis (36). 443 
Tyrosol had no effect on putative morphology-related genes (CPH2, EFG1, UME6, OCH1, 444 
SPT3, CWH41), which is in line with our microscopic observations. 445 
Regarding antifungal susceptibility, a clear antagonistic interaction was observed between 446 
fluconazole and tyrosol both against planktonic cells and biofilms. Tyrosol increased the 447 
expression of MDR1 and CDR1 orthologs, as well as the FCR1, C1_00830W, and 448 
CPAR2_405280 drug transporter genes in C. parapsilosis, which may explain the observed 449 
antagonistic interactions. In contrast, in previous studies, farnesol exposure decreased the 450 
expression level of MDR1 and CDR1 as well as ERG genes, which was associated with the 451 
observed reversion of azole resistance in C. albicans (37-38). In C. parapsilosis, neither 452 
MDR1 nor CDR1 genes were influenced by farnesol (39). Furthermore, ergosterol 453 
biosynthesis genes were not affected by tyrosol; therefore, the observed antagonistic 454 
interaction was probably not linked to the ergosterol pathway but was rather due to the 455 
overexpression of the abovementioned efflux pumps. 456 
Based on our in vivo experiments, the daily intraperitoneal treatment with 15 mM tyrosol for 457 
five days significantly reduced the fungal kidney burden in systemic infection with CLIB 214, 458 
which was in parallel with the results of the gene expression pattern. The transcriptional 459 
profiling showed that genes involved in adhesion (ALS6) had reduced expression in response 460 
to tyrosol. In addition, genes encoding secreted aspartyl proteinases (SAPP1 and SAPP3) (40) 461 
were not up-regulated significantly, which may explain the above-mentioned decreased in 462 
vivo virulence. Furthermore, down-regulation of the expression of FAD2 and FAD3 coding 463 
for proteins involved in PUFA synthesis may also contribute to lower virulence by decreasing 464 




To the best of our knowledge, this is the first study analysing changes in gene expression in 466 
C. parapsilosis following tyrosol exposure using RNA-Seq (26), providing important insights 467 
into the mechanism of antifungal action of tyrosol and the response of C. parapsilosis, which 468 
may aid in the better understanding of tyrosol-related antifungal activity in non-albicans 469 
species. In summary, tyrosol exposure enhanced the oxidative stress response and up-470 
regulated efflux pumps, while inhibiting growth and ribosome biogenesis as well as virulence. 471 
Metabolism was modulated towards glycolysis and ethanol fermentation. Initial adherence 472 
was not influenced by the presence of tyrosol. Our findings suggest that tyrosol may be a 473 
potential locally active and/or adjuvant agent in the development of alternative treatments 474 
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Table 1 Tyrosol-induced oxidative stress response in Candida parapsilosis 616 
 617 
Mean ± standard deviation values calculated from three independent experiments are 618 
presented. 619 
* , ***
 Significant differences at p<0.05 and 0.001, respectively, as calculated by the paired 620 
Student’s t-test compared to untreated control and tyrosol-treated cultures. 621 
Oxidative stress related 
parameter 
Untreated cultures TTyrosol-treated cultures 
Catalase  
[kat (kg protein)-1] 
1.4 ± 0.24 2.2 ± 0.4 * 
GR [mkat (kg protein)-1] 8.9 ± 0.4 9.6 ± 0.5 
GPx [mkat (kg protein)-1] 1.8 ± 0.3 2.5 ± 0.4 * 
SOD [munit (mg protein)-1] 72.5 ± 4.5 129.4 ± 10.9 * 
DCF [nmol DCF (OD640)




Table 2 Summary of selected significant shared Gene Ontology (GO) terms. 622 
 623 
Comparison 





 for up regulated genes
c







Cell surface (16), Cell wall (18), Hyphal cell wall 
(13), Extracellular matrix (14), Peroxisomal matrix 
(5), Biofilm matrix (14) 
Carbohydrate metabolic process (32), Glycolytic 
process (11), Glycolytic fermentation (4), Purine 
nucleotide biosynthetic process (12) 
Response to oxidative stress (18), Oxidoreductase 
activity (38), Peroxidase activity (5), Cofactor 
binding (29), Drug catabolic process (8), Positive 
regulation of defense response (6) 
Transmembrane transport (42), rRNA transport (6), 
Amino acid transport (11), Anion transmembrane 
transporter activity (14) 
Cell wall (14), Hyphal cell wall (8), Cytosol (28), 
Cytosolic ribosome (26) 
Translation (34), Cytoplasmic translation (12), 
Ribosome biogenesis (25), Large ribosomal subunit 
(14), Small ribosomal subunit (12) 
 624 
a
 - Significant shared GO terms (p<0.05) were determined with Candida Genome Database Gene Ontology Term Finder 625 
(http://www.candidagenome.org/cgi-bin/GO/goTermFinder). Table contains selected significant shared terms only. The whole data set is 626 
available in Supplementary Table 3. 627 
b
 - Up- and down-regulated genes were defined as differentially expressed genes (corrected p value < 0.05) where log2(FC) > 0.585 or log2(FC) < 628 
− 0.585, respectively, and FC stands for fold change FPKM value. 629 
c




Legends to the Figures 631 
Figure 1 632 
Effect of tyrosol on the growth of C. parapsilosis. 633 
Growth of C. parapsilosis CLIB 214 was followed in YPD medium by measuring of 634 
absorbance (OD640). Tyrosol was added at four hours incubation time at a 15 mM final 635 
concentration. Figures represent mean ± SD values calculated from ten independent 636 
experiments. Asterix symbols represents significant difference between control and tyrosol-637 
treated cultures calculated by paired Student’s t-test. 638 
 639 
Figure 2 640 
Results of in vivo experiments. 641 
Kidney tissue burden of the permanent neutropenic BALB/c mice infected intravenously with 642 
the C. parapsilosis strain CLIB 214. Daily intraperitoneal tyrosol (15 mM) treatment was 643 
started at 24 hours post-inoculation. Fungal kidney tissue burden was determined at the end of 644 
the experiments on day six. Bars represent mean ± SD. The level of statistical significance 645 
compared with the untreated control group on day six is indicated: **p < 0.01. 646 
 647 
Figure 3 648 
Correlation between RT-qPCR and transcriptome data. 649 
RNA-Seq data are presented as log2FC values, where by FC is short for “fold change”. 650 
Relative transcription levels were quantified with ΔΔCP = ΔCPcontrol – ΔCPtreated. ΔCPtreated = 651 
CP test gene - CPreference gene measured from treated cultures. ΔCPcontrol = CP test gene - CPreference gene 652 
measured from control cultures. CP values represented the qRT-PCR cycle numbers of 653 




p < 0.05, n = 3) higher or lower than zero ΔΔCP values (up- or down-regulated genes) are 655 
marked with red and blue colours, respectively. The Pearson’s correlation coefficient between 656 
the RT-qPCR and RNA-seq values was 0.88. 657 
 658 
Figure 4 659 
Genome-wide transcriptional changes induced by tyrosol in C. parapsilosis 660 
Up-regulated (red) and down-regulated (dark blue) genes were defined as differentially 661 
expressed genes (corrected p-value < 0.05) where log2(FC)>0.585 or log2(FC)< –0.585, 662 
respectively, and FC stands for fold change FPKM value (tyrosol treated vs. untreated). 663 
Figures, on the sides of the volcano plot, presents representative genes up-regulated or down-664 
regulated by tyrosol treatment. 665 
 666 
Supplementary Figure 1: Cluster (A) and principal component (B) analysis of the 667 
transcriptome data. 668 
Symbols represent untreated control (Cont) and 15 mM tyrosol exposure (Tyr) cultures. 669 
Analyses were performed with the StrandNGS software using default settings. 670 
 671 
Supplementary Table 1: Oligonucleotide primers used for RT-qPCR analysis. 672 
 673 
Supplementary Table 2: Results of the RT-qPCR measurements. 674 
Relative transcription levels were quantified with ΔΔCP = ΔCPcontrol – ΔCPtreated, where 675 
ΔCPtreated = CPtested gene – CPreference gene measured from treated cultures and ΔCPcontrol = CPtested 676 
gene – CPreference gene measured from control cultures. CP values stand for the qRT-PCR cycle 677 
numbers of crossing points. RT-qPCR data are presented as mean ± SD calculated from three 678 




were compared using Student’s t-test (p<0.05). Significantly higher or lower than zero ΔΔCP 680 
values (up- or down-regulated gene) are marked with red and blue colours. 681 
 682 
Supplementary Table 3: Results of the gene set enrichment analysis. 683 
Significant shared GO terms (p < 0.05) were determined with the Candida Genome Database 684 
Gene Ontology Term Finder (http://www.candidagenome.org/cgi-bin/GO/goTermFinder). 685 
Up- and down-regulated genes were defined as differentially expressed genes where log2(FC) 686 
> 0.585 or log2(FC) < −0.585 and FC stands for fold change FPKM value. Biological 687 
processes, molecular function and cellular component categories are provided. Terms 688 
highlighted with yellow are presented in Table 2. 689 
 690 
Supplementary Table 4: Transcription data of selected gene groups. 691 
Part 1: Selected genes involved in genetic control of Candida parapsilosis virulence. 692 
Part 2: Selected genes involved in glucose catabolism. 693 
Part 3: Selected signal transduction, transmembrane transport, and ribosome biogenesis genes.  694 
Part 4: Selected genes involved in oxidative stress defence. 695 
The systematic names, gene names, gene orthologs in Candida albicans and the features 696 
(putative molecular function or biological process) of the genes are given according to the 697 
Candida Genome Database (http://www.candidagenome.org). Up- and down-regulated genes 698 
were defined as differentially expressed genes (corrected p-value < 0.05) where 699 
log2(FC)>0.585 or log2(FC)< –0.585, respectively, and FC stands for fold change FPKM 700 
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Fatty acid metabolism: FAD2, FAD3 
Morphology: CZF1 
Biofilm- Maturation: CZF1, RBT1, 
IFD6, ADH5, TEC1, HGC1 
Biofilm- Dispersion: NRG1  
Drug transporters: CDR1, MDR1, 
C1_00830W, CPAR2_405280, FCR1 
Glycolysis: PGI1, PFK1, PFK2, 
TDH3, PGK1, GPM2, ENO1, CDC19 
Fermentation: PDC11, PDC12, 
ADH1, ADH5, ADH7 
Glycerol biosyntesis: RHR2 
Oxidative stress 
Antioxidant enzymes: CAT1, SOD4, 
CPAR2_803850, GST2, AHP1, GPX1 
Regulation and other functions: 
CAP1, PST1, CIP1, GND1, MSN4, 
TAC1, SRR1, XBP1, POS5, 
C3_06860C_A 
Signal transduction: RIM101, 
MSB2, DPL1, SRR1, CPP1, PHO84 
Ribosome biogenesis 
Small subunit genes: RPS3, RPS15, 
TIF5, YST1 etc. 
Large subunit genes: RPL5, RPL8B, 
RPL25, RPP2A etc. 
Transport 
Amino acid: GAP1, GAP4, PUT4, 
DIP5, GNP3, MUP1,  AGP3, ARG11, 
UGA1 
Carbohydrate: HGT1, HGT10, 
HGT13, HGT14, HGT17, YOR1, 
NGT1, NAG3-4, HXT5 
Lactate: JEN2, Sulfate:SUL2 
Zinc: ZRT2, Iron: SIT1 
Alcohol: HOL1 
Nucleosid: NUP, FCY21 
Signal transduction: MKC1, RGS2, 
PDE2  
Cell wall organization: RHD3, 
PGA30, IFF6 



















Cell wall organization: GPH1, 
EXG2, WSC1, XYL2, GPM2 
